Талшын Муратовна Тленчиева

Mrs. Талшын Муратовна Тленчиева

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
AKAslan Kerimbayev
Aslan Kerimbayev
The research conducted in this preclinical study assesses QazCovid-live, a live attenuated COVID-19 vaccine created in Kazakhstan, by conducting preclinical evaluations of safety, immunogenicity, and allergenicity in various animal models, including mice, rats, hamsters, and guinea pigs. The vaccine, developed by attenuating SARS-CoV-2 via numerous Vero cell passages, had no significant adverse effects in acute and subacute toxicity assessments, even at elevated dosages. Allergenicity testing indicated the absence of both immediate and delayed hypersensitivity reactions. Immunogenicity evaluations revealed strong virus-neutralizing antibody responses, especially following intranasal and intratracheal delivery. Studies on reversibility and transmission further validated the vaccine’s stability and non-pathogenicity. The data indicate that QazCovid-live is safe, immunogenic, and prepared for clinical trials, presenting a potential strategy for COVID-19 prevention.

9 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
KBKarina Bisenbayeva
Karina Bisenbayeva
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
Peste des petits ruminants (PPR) is an extremely contagious viral disease that significantly affects the health of small ruminants and the economies of livestock, particularly in areas adjacent to endemic regions. This study focused on assessing the vulnerability of different domestic and wild animal species in Kazakhstan, which includes local sheep and goats, African Cameroon goats, saigas, calves, and ground squirrels, to infection by the PPR virus (PPRV). Experimental infections used a virulent strain of PPRV (Nigeria 76/1), with animals being monitored over a period of 21–28 days to evaluate clinical signs, pathological lesions, and viral dissemination. The manifestation of disease differed across species, breed, and age. In Cameroon, goats and saigas displayed severe illness with a mortality rate of 100% and elevated virus levels in key organs, whereas local sheep and goats presented age-related subacute, abortive, and latent manifestations. Calves exhibited mild, subclinical infections, while ground squirrels showed no susceptibility. Viral shedding was observed in the secretions of infected animals, with transmission occurring through airborne and alimentary pathways. No virus carriage was detected in the animals that had recovered. The investigation emphasizes the notable variations in PPRV pathogenesis and transmission risk among different species, highlighting the necessity for focused surveillance and control strategies to avert incursions in PPR-free areas like Kazakhstan.

31 May 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
AKAslan Kerimbayev
Aslan Kerimbayev
Background/Objectives: Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no licensed monovalent vaccine for EHV-4, and existing formulations offer limited protection against this serotype. This study aimed to develop and evaluate a freeze-dried, live-attenuated EHV-4 vaccine with improved safety, stability, and immunogenicity. Methods: A field isolate of EHV-4 was attenuated through serial passaging in primary lamb testicle (LT-KK49) cell cultures. Viral biomass was concentrated and formulated with various stabilizers before freeze-drying. The most effective stabilizer composition—sucrose, gelatin, and lactalbumin hydrolysate—was selected based on viral titer retention. Safety and immunogenicity were assessed in mice, guinea pigs, rabbits, donkeys, and horses. A guinea pig reproductive challenge model was used to evaluate protective efficacy. Results: The optimized lyophilized vaccine retained infectivity (>6.0 log10 TCID50/cm3) for at least six months at 4 °C. No adverse clinical signs were observed in any test species. Immunization induced robust neutralizing antibody responses in both small animals and equines. In the guinea pig model, vaccinated females demonstrated 100% pregnancy retention and fetal viability following challenge with a virulent EHV-4 strain. Conclusions: This freeze-dried, live-attenuated EHV-4 vaccine candidate is safe, immunogenic, and thermostable. It offers a promising platform for the targeted prevention of EHV-4 infection, particularly in young horses and in regions with limited cold-chain infrastructure.

12 November 2024 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
KBKarina Bisenbayeva
Karina Bisenbayeva
ATAiganym Tussipova
Aiganym Tussipova
LKLespek Kutumbetov
Lespek Kutumbetov
The territory of the Republic of Kazakhstan is unfavorable for a number of infectious diseases of animals and humans that pose an enzootic biological threat. Such nosological units include anthrax, blackleg, rabies, leukemia, brucellosis, tuberculosis, pasteurellosis, sheep pox, camel pox, CCHF, highly pathogenic avian influenza, foot-and-mouth disease, tick-borne encephalitis, influenza A and B, infectious hepatitis, Newcastle disease, seasonal flu, coronavirus infection COVID-19, etc., some of which affect only animals or humans, and some affect both animals and humans. While some of these diseases are natural focal and pose a constant biological threat, others appear from time to time, penetrating from neighboring countries or develop as a result of movement from the wild - reservoirs and hidden carriers of pathogens. A number of exotic diseases pose a real threat of penetration from outside the country due to interstate movements of people, animals, feed and animal products.

27 June 2025 in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
Verified
Journal Article
Open access
PDF file
ATAiganym Tussipova
Aiganym Tussipova
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
KBKarina Bisenbayeva
Karina Bisenbayeva
LKLespek Kutumbetov
Lespek Kutumbetov
Crimean-Congo Hemorrhagic Fever (CCHF) is a high mortality, tick-borne viral illness endemic to Africa, Asia, the Middle East, and certain regions of Europe. Notwithstanding its peril to public health, there is presently no licensed vaccination available. This study highlights important progress and challenges in developing CCHF vaccines, including traditional methods (inactivated and live-attenuated vaccines) and new approaches (subunit, DNA, mRNA, and viral vectors). We also investigate the functions of adjuvants and delivery technologies – such as nanoparticles and viral vectors – in enhancing immunogenicity and safety. Insights from historical endeavors and recent advancements underscore the pressing necessity for safe, effective, and scalable vaccinations, especially in endemic areas. Future initiatives must emphasize cross-protective formulations, thermal stability, and international cooperation.

14 October 2023 in Biosafety and Biotechnology
Verified
Journal Article
Open access
PDF file
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
GZGulzhan Zhapparova
Gulzhan Zhapparova
KBKarina Bisenbayeva
Karina Bisenbayeva
ATA. S. Toitanova
A. S. Toitanova
LKLespek Kutumbetov
Lespek Kutumbetov
This review article addresses the etiology, epidemiology, distribution of Crimean-Congo hemorrhagic fever (CCHF), and its diagnosis and prevention. Crimean-Congo hemorrhagic fever (CCHF) is one of the deadly hemorrhagic fevers endemic in Africa, Asia, and Europe. It is a tick-borne zoonotic viral disease caused by the CCHF virus of the genus Nairovirus, family Bunyaviridae. In Kazakhstan, natural foci of CCHF are located in the Zhambyl, Turkestan, and Kyzylorda regions, as well as the city of Shymkent. In Kazakhstan, 108 confirmed cases of CCHF were registered in humans during the period from 2021 to 2023. The virus genome consists of small (S), medium (M), and large (L) segments, encoding nucleocapsid proteins (N), envelope glycoproteins (G1 and G2), and polymerase complex proteins, respectively. Most human cases were associated with agricultural activities such as animal husbandry, haymaking, and livestock slaughter. Humans are most commonly infected by tick bites. Clinical signs usually indicate the rapid progression of the disease, which is accompanied by bleeding, muscle pain, and fever. Now, there is no specific treatment, and the most important measures are preventive safety practices. For the diagnosis of CCHF, methods such as ELISA, RT-PCR, and real-time RT-PCR are used